WVE - WAVE Life Sciences L...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $6.34 | Open | $6.40 |
| Volume | 334.2K | Market Cap | 816.42M |
| Yield | Last Dividend |
| Wave Life Sciences : Fourth Quarter 2020... | 03/04/21 |
| Wave Life Sciences Fourth Quarter and Full Year 2020 Earnings March 4, 2021 Forward-looking statements ??? | March 4, 2021 | |
| Earnings Scheduled For March 4, 2021 | 03/04/21 |
| Companies Reporting Before The Bell ??? Toro (NYSE: TTC ) is expected to report quarterly earnings at $0.75 per share on revenue of $851.38 million. ?... | |
| Wave Life Sciences (NASDAQ:WVE) Price Ta... | 11/20/20 |
| Wave Life Sciences (NASDAQ:WVE) had its target price lowered by analysts at Mizuho from $21.00 to $19.00 in a report released on Friday, The Fly repor... | |
| Wave Life Sciences to Webcast Conference... | 10/26/20 |
| CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to??? | |
| Wave Life Sciences (NASDAQ:WVE) Coverage... | 10/22/20 |
| Royal Bank of Canada assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE) in a research note released on Thursday, The Fly reports. The broke... | |
| Royal Bank of Canada Initiates Coverage ... | 10/22/20 |
| Equities researchers at Royal Bank of Canada assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE) in a report issued on Thursday, The Fly rep... | |
| Wave Life Sciences (NASDAQ:WVE) Now Cove... | 10/22/20 |
| Investment analysts at Royal Bank of Canada assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE) in a research note issued on Thursday, The F... | |
| -$0.73 EPS Expected for Wave Life Scienc... | 10/20/20 |
| Wall Street brokerages expect that Wave Life Sciences Ltd. (NASDAQ:WVE) will announce ($0.73) earnings per share (EPS) for the current fiscal quarter,... | |
| WAVE Life Sciences: Q2 Earnings Insights | 08/10/20 |
| Shares of WAVE Life Sciences (NASDAQ:WVE) moved higher by 1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings p... | |
| Wave Life Sciences to Webcast Conference... | 07/27/20 |
| CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to??? | |
| 11 major companies that have returned mi... | 04/27/20 |
| The $349 billion Paycheck Protection Program launched in early April was meant to bolster struggling small businesses . It was aimed at providing busi... | |
| Wave Life Sciences Enters Oversold Terri... | 01/14/20 |
| Wave Life Sciences Ltd. (WVE) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. | |
| Wave Life Sciences News: WVE Stock Crash... | 12/30/19 |
| Wave Life Sciences (WVE) news for Monday has WVE stock taking a beating on early data from its Huntington???s disease trial. | |
| Options Traders Expect Huge Moves in Wav... | 12/23/19 |
| Investors need to pay close attention to Wave Life Sciences (WVE) stock based on the movements in the options market lately. | |
| Wave Life Sciences News: WVE Stock Slamm... | 12/16/19 |
| Wave Life Sciences (WVE) news for Monday about it giving up on a Duchenne muscular dystrophy drug is hitting WVE stock hard. | |
| Wave Life Sciences Stock Folds on Drug D... | 12/16/19 |
| Wave Life said it would stop the development of its DMD drug, suvodirsen | |
| Asuragen Partners with Wave Life Science... | 11/25/19 |
| AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and on... | |
| Wave Life Sciences (WVE) Expected to Bea... | 11/01/19 |
| Wave Life Sciences (WVE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi... | |
| The Daily Biotech Pulse: European Cheer ... | 07/30/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) ... | |
| The Daily Biotech Pulse: Setback For Bri... | 07/25/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) ... | |
| Wave Life Sciences files for $250M mixed... | 05/10/19 |
| No summary available. | |
| Wave Life Sciences (WVE) Reports Q1 Loss... | 05/10/19 |
| Wave Life Sciences (WVE) delivered earnings and revenue surprises of -14.29% and -68.69%, respectively, for the quarter ended March 2019. Do the numbe... | |
| Wave Life Sciences misses by $0.17, miss... | 05/10/19 |
| No summary available. | |
| Wave Life Sciences (WVE) May Report Nega... | 05/01/19 |
| Wave Life Sciences (WVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepa... | |
| Wave Life Sciences Plunges After DMD Stu... | 04/17/19 |
| Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage ... | |
| Midday Gainers / Losers | 04/16/19 |
| No summary available. | |
| Wave Life Sci presents final safety data... | 04/16/19 |
| No summary available. | |
| Spotlight On Earnings, Pinterest And App... | 04/14/19 |
| No summary available. | |
| Stocks To Watch: Spotlight On Earnings, ... | 04/13/19 |
| No summary available. | |
| NASH players in the red as EASL announce... | 04/11/19 |
| No summary available. | |
| Buy rating | 03/30/21 |
| and lowers Price Target from $10.00 to $7.00 | |
| Date | 2021-03-04 (BMO) | Est. (EPS/Rev.) | ($0.61)/ 9.75M |
| Actual (EPS/Rev.) | $-0.59/ $9.44 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
